Nucleotide sequence of the equine interferon gamma cDNA.

The research focuses on the cloning of equine IFN gamma cDNA, which is relevant in the immune response. The equine IFN gamma cDNA shows 67% similarity to human equivalent and 78% to the bovine equivalent.

Introduction

• The article discusses research conducted on Interferon gamma (IFN gamma), a cytokine produced by T-lymphocytes and natural killer cells.
• Cytokines are proteins that play a significant role in cell signalling. They are critical in coordinating responses in the immune system.
• Specifically, the research paper focuses on the cloning of the equine IFN gamma cDNA, relating to horses.

Functions and Importance of IFN Gamma

• Interferon gamma plays a central role in modulating the immune response. This means it helps regulate our bodies’ defense systems against foreign organisms, including viruses and bacteria.
• Its properties, including its antiviral and anti-tumorigenic characteristics, have made IFN gamma a viable candidate for use in prophylactic and therapeutic regimes.
• These properties suggest that IFN gamma could potentially be used in preventive healthcare (prophylactic) or treatment regimes against various diseases, including cancer (therapeutic regimes).

Cloning of Equine IFN Gamma cDNA

• The research included cloning the equine IFN gamma cDNA, i.e., creating copies of this particular portion of the horse’s DNA.
• Cloning this DNA enables scientists to produce more of the equine IFN gamma cytokine and potentially use it for clinical evaluation in horses, i.e., assess its potential use in treating or preventing diseases in horses.

Comparison with Human and Bovine Equivalents

• The research found that the predicted equine IFN gamma amino acid sequence is 67% identical to that of the human equivalent. This significant similarity could potentially facilitate future cross-species research or applications.
• The sequence was also found to be 78% identical to the bovine equivalent, an even closer match. This could suggest the possibility of similar immune responses or prophylactic/therapeutic potential between horses and cows.